Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9284543 Neutral active soluble truncated PH20 polypeptides and uses thereof

Patent 9284543 was granted and assigned to Halozyme, Inc. on March, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Louis Bookbinder0

Ge Wei0

Gregory I. Frost0

Krishnasamy Panneer Selvam0

Date of Patent

March 15, 2016

0

Patent Application Number

133855270

Date Filed

February 21, 2012

0

Patent Citations Received

US Patent 12110520 PH20 polypeptide variants, formulations and uses thereof

0

US Patent 12104185 PH20 polypeptide variants, formulations and uses thereof

0

US Patent 11952600 PH20 polypeptide variants, formulations and uses thereof

0

US Patent 12018298 PH20 polypeptide variants, formulations and uses thereof

0

0

US Patent 12060590 PH20 polypeptide variants, formulations and uses thereof

0

0

US Patent 12077791 PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof

0

...

Patent Primary Examiner

0

Patent abstract

Soluble PH20 polypeptides are provided, including extended soluble PH20 polypeptides, and uses thereof. Also provided are other C-terminally truncated PH20 polypeptides and partially deglycosylated PH20 polypeptides and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9284543 Neutral active soluble truncated PH20 polypeptides and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool